|
|||||
|
|
Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced‐stage follicular lymphoma: A cost‐effectiveness analysis |
|
| Authors: | Anca Prica Kelvin Chan Matthew Cheung |
| Affiliation: | 1. Division of Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada;2. Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada;3. Division of Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada |
| Abstract: | |
| Keywords: | cost‐effectiveness follicular lymphoma quality of life rituximab therapy |